Revance Therapeutics Inc (NASDAQ: RVNC) kicked off on Friday, down -4.13% from the previous trading day, before settling in for the closing price of $3.39.
Revance Therapeutics Inc (NASDAQ: RVNC) on Monday, soared 12.30% from the previous trading day, before settling in for the closing price of $3.09. Within the
Revance Therapeutics Inc (NASDAQ: RVNC) flaunted slowness of -0.65% at $3.04, before settling in for the price of $3.06 at the close. Taking a more
Revance Therapeutics Inc (NASDAQ: RVNC) kicked off on Tuesday, up 0.33% from the previous trading day, before settling in for the closing price of $3.07.
Witnessing the stock’s movement on the chart, on Thursday, Revance Therapeutics Inc (NASDAQ: RVNC) remained unchanged to $3.07, before settling in for the price of
On Friday, Revance Therapeutics Inc (NASDAQ: RVNC) was -0.32% drop from the session before settling in for the closing price of $3.09. A 52-week range
Revance Therapeutics Inc (NASDAQ: RVNC) open the trading on Wednesday, with great promise as it jumped 0.50% to $3.04, before settling in for the price
Revance Therapeutics Inc (NASDAQ: RVNC) on Friday, plunged -3.05% from the previous trading day, before settling in for the closing price of $3.94. Within the
Revance Therapeutics Inc (NASDAQ: RVNC) established initial surge of 6.38% at $4.17, before settling in for the price of $3.92 at the close. Taking a
Revance Therapeutics Inc (NASDAQ: RVNC) kicked off on Friday, down -4.50% from the previous trading day, before settling in for the closing price of $3.78.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
